-

Agilent Receives Two Scientists’ Choice Awards

Innovative instruments receive top honors from members of SelectScience

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that two of the company’s instruments have received Scientists’ Choice awards. The Agilent 8890 GC system won for Best New Separations Product, and the Agilent InfinityLab LC/MSD iQ system won for Best New Spectroscopy Product.

SelectScience, an independent, expert-led scientific review, began the Scientists’ Choice Awards in 2007 to enable scientists to voice their opinions on the best laboratory products. Each year, SelectScience invites members to nominate their favorite products in various categories. The awards are based on member votes and recognize the innovation and impact these products have had on the market.

“We are delighted to have received these awards,” said Jacob Thaysen, senior vice president, Agilent and President, Life Sciences and Applied Markets Group (LSAG). “We work hard to create innovative solutions to meet the evolving needs of our customers—particularly the need to simplify their workflows, improve productivity, and reap the benefits of greater connectivity. These awards are a recognition of our continued investment in research and development for the future of the laboratory.”

Both Agilent systems integrate next-generation intelligence, including diagnostic tools and software that ensure pro-active maintenance for maximum uptime and greater sample throughput.

The award for the 8890 reflects the value chromatographers see in these state-of-the-art smart connected technologies. Combined with the system’s flexible configurability, the 8890 is able to meet chromatographic needs today and well into the future.

This is the third award for the InfinityLab LC/MSD iQ system since launching in 2019, a reflection of how the system’s ease of use makes LC/MS technology accessible to chromatographers. The system has previously been recognized by The Analytical Scientist and The Medicine Maker 2019 Innovation awards.

Winners were announced at Pittcon 2020, the world’s largest annual conference and exposition on laboratory science, in Chicago, Illinois.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Catherine Kaye
Agilent Technologies
+447775 410632
catherine.kaye@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

Catherine Kaye
Agilent Technologies
+447775 410632
catherine.kaye@agilent.com

More News From Agilent Technologies Inc.

Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and production.The new SEC and PLRP-S columns support critical analytical workflows across a range of biotherapeutic modalities, including peptides, proteins, oligonucleotides...

Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software upgrade enhances the unique dual-readout capabilities of the Agilent xCELLigence RTCA eSight instrument with AI-driven cell imaging analysis, enabling researchers to...

Agilent Completes Acquisition of Biocare Medical

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group.“We are pleased to complete our acquisition of Biocare, which represents a natural and st...
Back to Newsroom